Stereogenic Centers

The demand for chiral organic entities for different industrial purposes has grown exponentially in the last decades. Concerns about controlling the stereochemistry of the new synthesized molecules increased significantly when the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) launched regulations about the use of chiral molecules not only for pharmaceutical uses, but also for agrochemicals, cosmetics